Advanced Manufacturing Strategies in Biologics: Process Intensification and the Future of Continuous Production
  The imperative to reduce the high cost of goods sold (COGS) for biologics, particularly in the face of rising biosimilar competition and payer scrutiny, is driving a revolution in manufacturing strategies centered on process intensification and the shift toward continuous production. Process intensification involves increasing the productivity of a given bioreactor volume through...
0 Comentários 0 Compartilhamentos 20 Visualizações 0 Anterior